Literature DB >> 27035910

A ring closing metathesis strategy for carbapyranosides of xylose and arabinose.

Clayton E Mattis1, David R Mootoo2.   

Abstract

The synthesis of β-carba-xylo and arabino pyranosides of cholestanol is described. The synthetic strategy, which is analogous to the Postema approach to C-glycosides, centers on the ring closing metathesis of an enol ether-alkene precursor to give a cyclic enol ether that is elaborated to a carba-pyranoside via hydroboration-oxidation on the olefin. The method, which is attractive for its modularity and stereoselectivity, may find wider applications to carba-hexopyranosides and other complex cycloalkyl ether frameworks.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Arabinose; Carbasugar; Cholestanol (PubChem CID: 6665); Cycloalkyl ether; Dimethyl sulfide borane (PubChem CID: 9833925); Glycomimetic; Grubbs catalyst 2nd generation (PubChem CID: 11147261); Methyl (triphenylphosphoranylidene)acetate (PubChem CID: 17453); Methyl 2,3-O-isopropylidene-beta-d-ribofuranoside (PubChem CID: 96666); Methyl alpha-d-arabinofuranoside (PubChem CID: 11389582); RCM; Tebbe reagent (PubChem CID: 91617563); Xylose

Mesh:

Substances:

Year:  2016        PMID: 27035910      PMCID: PMC5137374          DOI: 10.1016/j.carres.2016.03.002

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  20 in total

1.  Total synthesis of the neotropical poison-frog alkaloid (-)-205B.

Authors:  Amos B Smith; Dae-Shik Kim
Journal:  Org Lett       Date:  2005-07-21       Impact factor: 6.005

2.  Synthesis of cardiac glycoside analogs by catalyst-controlled, regioselective glycosylation of digitoxin.

Authors:  Thomas M Beale; Mark S Taylor
Journal:  Org Lett       Date:  2013-03-06       Impact factor: 6.005

Review 3.  Natural glycoconjugates with antitumor activity.

Authors:  Barbara La Ferla; Cristina Airoldi; Cristiano Zona; Alexandre Orsato; Francisco Cardona; Silvia Merlo; Erika Sironi; Giuseppe D'Orazio; Francesco Nicotra
Journal:  Nat Prod Rep       Date:  2010-11-30       Impact factor: 13.423

Review 4.  Carbohydrate molecules: an expanding horizon in drug delivery and biomedicine.

Authors:  Raj Kumar Shukla; Akanksha Tiwari
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2011       Impact factor: 4.889

5.  OSW-1: a natural compound with potent anticancer activity and a novel mechanism of action.

Authors:  Yan Zhou; Celia Garcia-Prieto; Dennis A Carney; Rui-hua Xu; Helene Pelicano; Ying Kang; Wensheng Yu; Changgang Lou; Seiji Kondo; Jinsong Liu; David M Harris; Zeev Estrov; Michael J Keating; Zhendong Jin; Peng Huang
Journal:  J Natl Cancer Inst       Date:  2005-12-07       Impact factor: 13.506

6.  Digitoxin analogues with improved anticytomegalovirus activity.

Authors:  Hongyi Cai; Hua-Yu L Wang; Rajkumar Venkatadri; De-Xue Fu; Michael Forman; Sumit O Bajaj; Hongyan Li; George A O'Doherty; Ravit Arav-Boger
Journal:  ACS Med Chem Lett       Date:  2014-01-25       Impact factor: 4.345

Review 7.  The amphiphilic nature of saponins and their effects on artificial and biological membranes and potential consequences for red blood and cancer cells.

Authors:  Joseph H Lorent; Joëlle Quetin-Leclercq; Marie-Paule Mingeot-Leclercq
Journal:  Org Biomol Chem       Date:  2014-11-28       Impact factor: 3.876

Review 8.  Naturally occurring triterpenoid saponins.

Authors:  Biswanath Dinda; Sudhan Debnath; Bikas Chandra Mohanta; Yoshihiro Harigaya
Journal:  Chem Biodivers       Date:  2010-10       Impact factor: 2.408

9.  New Taxol (paclitaxel) prodrugs designed for ADEPT and PMT strategies in cancer chemotherapy.

Authors:  Abdessamad El Alaoui; Nabendu Saha; Frédéric Schmidt; Claude Monneret; Jean-Claude Florent
Journal:  Bioorg Med Chem       Date:  2006-03-22       Impact factor: 3.641

10.  The carbamoylmannose moiety of bleomycin mediates selective tumor cell targeting.

Authors:  Chandrabali Bhattacharya; Zhiqiang Yu; Michael J Rishel; Sidney M Hecht
Journal:  Biochemistry       Date:  2014-05-13       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.